Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture

Summary

This NIHR HTA-funded evidence synthesis aims at assessing the clinical and cost-effectiveness of collagenase clostridium histolyticum injections, within its licensed indication, as an alternative to surgery (including fasciectomy, dermofasciectomy, open fasciotomy and needle fasciotomy) for the treatment of adults presenting with Dupuytren’s contracture with a palpable cord. Estimated publication date for this assessment is March 2015. For further information see: http://www.nets.nihr.ac.uk/projects/hta/130501.

Contact

Miriam Brazzelli; m.brazzelli@abdn.ac.uk

Status

Completed